US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market.

The Falcon 9 rocket sent up the BlueBird 1-5 mission from Cape Canaveral’s Space Launch Complex 40.

It’s back to the drawing board for bluebird bio and its discussions with NICE, which has rejected its beta thalassaemia gene therapy Zynteglo for regular NHS use in first draft guidance.

The most up-to-date news, transfers and opinion on Cardiff City, who play in League One. You can get the latest Bluebirds updates sent straight to your inbox for free by signing up to our ...